Evidence map›Paper›PMID 19181811›Full record

ArticleJournal of bacteriology2009

Properties of HflX, an enigmatic protein from Escherichia coli.

Dipak Dutta, Kaustav Bandyopadhyay, Ajit Bikram Datta, Abhijit A Sardesai, Pradeep Parrack

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. DistinctiveFrontiers in plant science · 2022
    Article
  4. Mycobacterial HflX is a ribosome splitting factor that mediates antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  5. Review
  6. Review
  7. HflXr, a homolog of a ribosome-splitting factor, mediates antibiotic resistance.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. HflX protein protectsJournal of biosciences · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The universally conserved prokaryotic GTPases.Microbiology and molecular biology reviews : MMBR · 2011
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dipak DuttaDepartment of Biochemistry, Bose Institute, Kolkata, India.
Kaustav Bandyopadhyay
Ajit Bikram Datta
Abhijit A Sardesai
Pradeep Parrack
Bose Institute · INCentre for DNA Fingerprinting and Diagnostics · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Escherichia coli gene hflX was first identified as part of the hflA operon, mutations in which led to an increased frequency of lysogenization upon infection of the bacterium by the temperate coliphage lambda. Independent mutational studies have also indicated that the HflX protein has a role in transposition. Based on the sequence of its gene, HflX is predicted to be a GTP-binding protein, very likely a GTPase. We report here purification and characterization of the HflX protein. We also specifically examined its suggested functional roles mentioned above. Our results show that HflX is a monomeric protein with a high (30% to 40%) content of helices. It exhibits GTPase as well as ATPase activities, but it has no role in lambda lysogeny or in transposition.

Indexed as

Adenosine TriphosphatasesBacteriophage lambdaEscherichia coliEscherichia coli ProteinsGTP-Binding ProteinsGTP PhosphohydrolasesLysogenyAdenosine TriphosphatasesEscherichia coli ProteinsGTP-Binding ProteinsGTP PhosphohydrolasesHflX protein, E coli

Identifiers

PMID19181811
PMCPMC2655521
OpenAlexW2133769317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.